BioCentury
ARTICLE | Distillery Therapeutics

Autoimmune disease

July 25, 2017 8:34 PM UTC

Patient sample and mouse studies suggest promoting IL-9 secretion by type 2 innate lymphoid cells (ILC2s) could help treat RA. In RA patients receiving anti-inflammatory therapy, IL-9 secretion shifte...

BCIQ Target Profiles

Interleukin-9 (IL-9)